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Abstract
Introduction—Women facing complex and uncertain situations such as cancer in their families 
may seek information from a variety of sources to gain knowledge about cancer risk and reduce 
uncertainty. We describe and assess the relative importance of information sources about familial 
breast cancer at the individual, family, and healthcare provider levels influencing women’s 
reporting they had enough information to speak with daughters about breast cancer. This outcome 
we refer to as being informed about breast cancer.
Materials and Methods—Sister Study participants, a cohort of women with a family history of 
breast cancer, were surveyed on family cancer history, family communication, social support, and 
interactions with healthcare providers (n = 11,766). Adjusted percentages and 95% confidence 
intervals for being informed about breast cancer versus not being informed were computed for 
individual-, family-, and provider-level characteristics in three steps using multivariate logistic 
regression models.
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Results—We found 65% of women reported being informed about breast cancer while 35% did 
not. Having a trusted person with whom to discuss cancer concerns, having a lower versus higher 
perceived risk of breast cancer, having undergone genetic counseling, and being satisfied with 
physician discussions about breast cancer in their families were predictors of being informed about 
breast cancer.
Conclusions—Although acquiring objective risk information, such as through genetic 
counseling, may contribute to a basic level of understanding, communication with providers and 
within other trusted relationships appears to be an essential component in women’s reporting they 
had all the information they need to talk with their daughters about breast cancer.
Keywords
breast cancer; oncology; risk communication; genetic counseling; family communication; 
information management
Introduction
Communication within families about genetic risk for breast cancer is uniquely challenging 
because hereditary cancers affect not only the individual but are relational—both genetically 
and psychosocially.1 For the individual considering disclosure of genetic risk of cancer to 
family members, there can be tensions between the perceived responsibility to inform 
relatives, the desire to protect relatives from unnecessary worry, and the personal desire to 
maintain privacy about one’s health and genetic makeup.2–4 Communication of genetic risk 
is also influenced by factors such as cultural background, emotional closeness or distance 
between relatives, and open or closed family communication patterns.5–9
Complicating communication about familial cancer is the complexity of genetic information 
itself. The difficulty in understanding and conveying genetic risk information has been 
shown in studies that included both the public and medical professionals where a lack of 
awareness about the genetic heritability for breast and ovarian cancer risk from the paternal 
side of the family has been especially well documented.10,11 Recent calls for educational 
materials or the direct assistance of healthcare providers in helping people communicate 
with relatives about genetic risk highlights an important unmet need.12–17 In particular, 
whether a woman with a family history of breast cancer discusses familial cancer risk with 
her children or other relatives may well hinge on whether she believes she has enough 
information to do so.
Communication about familial breast cancer can be thought of as a way of both acquiring 
information and managing uncertainty—a theme of particular relevance to topics involving 
cancer risk and genetics. Research suggests, however, uncertainty in probabilistic, complex, 
or ambiguous situations cannot always be eliminated, but rather, would require management 
to reduce anxiety and worry.18,19 Uncertainty management theory posits that persons 
confronted with unpredictable or complex situations or events such as cancer in their family, 
will seek information from a variety of sources to manage uncertainty, or conversely, may 
avoid especially distressing information as a coping mechanism.18,20 Moreover, an 
individual seeking information may find that information from different sources may have 
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different and perhaps conflicting effects on their confidence about what they know and about 
the accuracy of their knowledge.
Cancer in a family member is a serious event and intrafamilial communication can convey 
both emotional support and important risk information.21 Outside the family, physicians 
remain the most trusted source of health information despite patients’ first seeking 
information on the Internet.22,23 At the individual level, information from different sources 
is integrated or filtered by factors such as education, age, and personal beliefs. Thus, a 
person’s understanding of her vulnerability to cancer may differ greatly from scientific 
understanding, and may remain limited even after being provided with genetic risk 
information.24–26 Furthermore, the accuracy of genetic information has been shown to 
decline as it moves from the clinic or healthcare provider to the family, and from one family 
member to another.27,28
We used a socio-ecologic conceptual model to frame demographic and psychosocial 
characteristics at the individual, family, and healthcare provider levels influencing a 
woman’s reporting she has enough information to speak with her daughter about breast 
cancer (Fig. 1, conceptual model).29 The aims of this analysis were to describe the 
characteristics that influence a woman’s reporting she is informed about breast cancer and 
identify the relative importance of those characteristics.
Materials and Methods
Participants
Data were obtained from a CDC-sponsored survey conducted among participants in the 
Sister Study cohort, a nationwide prospective cohort study of genetic and environmental risk 
factors for breast cancer among women with at least one sister diagnosed with breast cancer 
but who were themselves breast cancer-free at the time of the survey (https://
sisterstudy.niehs.nih.gov). Study design and methodology for the Sister Study is described at 
https://sisterstudy.niehs.nih.gov and in previous publications.30,31 At enrollment, all Sister 
Study respondents completed a baseline survey that included demographics, personal 
medical history and family history of cancer. The CDC Survey collected information on 
cancer screening, genetic counseling, genetic testing, and cancer prevention behaviors 
among the 21,189 women scheduled for their periodic follow-up in 2011–2012 who had not 
reported a breast cancer diagnosis. The study was approved by the Institutional Review 
Boards of the NIEHS/NIH and the Co-pernicus Group.
A total of 19,540 women completed the survey (response rate = 92.2%). Of these women, 
11,831 reported they had a daughter to whom they had given birth and were therefore 
eligible for this analysis. After excluding 19 women who reported a history of lobular 
carcinoma in situ or ductal carcinoma in situ and 84 women who did not answer the question 
on having enough information to speak with their daughter(s) about cancer in the family, the 
final sample size was 11,766 for analysis.
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Dependent variable—The outcome of interest was whether women agreed with the 
statement that they had “all the information they needed to speak with their daughter(s) 
about breast cancer.” The 4 item response categories were dichotomized into strongly 
disagree/disagree versus agree/strongly agree with having enough information. For 
consistency throughout the following text we refer to this outcome as “being informed about 
breast cancer.”
Individual level variables—Individual level characteristics included age, marital status, 
education level, a personal history of cancer other than breast cancer, and choice of survey 
administration (phone, paper, or online) that was used as a proxy for skill in navigating 
online resources (see Table 1 for categorization of variables). In addition, to assess a 
woman’s perceived risk of breast cancer, respondents were asked whether their lifetime 
chance of developing breast cancer was much lower, lower, about the same, higher, or much 
higher compared with other women their age. Responses were categorized into three levels: 
much lower/lower, the same, and higher/much higher. In previous studies this measure has 
demonstrated good sensitivity in identifying high-risk women32 and also was shown to 
influence genetic risk disclosure to family members.33
Family level variables—Family level factors included race/ethnicity, the number of first-
degree relatives with breast cancer, time since the respondent’s sister’s cancer diagnosis, and 
household income. Women also were asked whether they have a trusted person with whom 
to speak about their concerns about developing breast cancer. The 4-level response 
categories (strongly disagree to strongly agree) were dichotomized as agree/strongly agree 
versus disagree/strongly disagree.
Research suggests social support attenuates or buffers the effects of stressful events.34,35 
Thus, the response to an event such as a diagnosis of cancer in one’s family can be 
ameliorated through support offered by family members. Social support was measured with 
six items selected and adapted from the Medical Outcomes Study Social Support Survey 
Instrument36 and the Abbreviated Childhood Trauma Questionnaire that address the 
availability of informational, instrumental, or tangible assistance when needed as well as 
emotional support received during adulthood and childhood.37 Respondents were asked how 
often they could count on someone to provide emotional support (someone to confide in 
about problems, someone who will listen), how often they could count on someone for help 
(with daily chores or doctor’s appointments), how often there is someone in the immediate 
family who believed in her and wanted her success, how often there was a family member 
who is making her feel important, and how often there was a family member who during 
childhood believed in her, and how often there was a family member who during her 
childhood made her feel special. Responses categories included 1 (none of the time), 2 (a 
little of the time), 3 (some of the time), 4 (most of the time), and 5 (all of the time). 
Responses were summed and categorized roughly into quartiles ranging from lowest to 
highest social support. The Cronbach’s alpha for this scale was 0.86 demonstrating high 
internal consistency.
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We used a subset of communication-related questions from the Connection to the 
Experience of Cancer Scale (CONNECS) to describe family communication.38 Each 
respondent was asked about “how much time was spent talking with her sister before she 
was diagnosed with cancer,” “how much time was spent talking with her sister during her 
breast cancer diagnosis and treatment,” “how much time was spent talking with her sister 
about her breast cancer,” and “how much time was spent talking with family members about 
her sister’s cancer.” The 4-level response options included 1 (never), 2 (rarely), 3 
(sometimes), and 4 (often). Answers were summed across items and divided into thirds, 
creating high, medium, and low levels of family communication. The internal consistency 
for these 4 items was adequate (Cronbach’s alpha =0.74).
Provider level variables—We asked participants whether they had spoken with a 
healthcare provider about what their family history of breast cancer means for their own 
health and cancer risk (“no,” “yes a little,” “yes a lot”) and whether they had received 
genetic counseling because of their family history of cancer. Genetic counseling was defined 
as a discussion with a trained genetic counselor about family health history. We chose 
genetic counseling as a key provider variable because genetic counselors assess and discuss 
family history and risk of cancer before genetic testing and interpret results after genetic 
testing, making genetic counseling an important source of information on breast cancer. We 
also asked how satisfied respondents were with the level of communication they had with 
their doctor about their family cancer history and their own cancer risk. Responses were 
coded as a 5-point scale (“very satisfied,” “satisfied,” “neither satisfied nor dissatisfied,” 
“dissatisfied,” or “very dissatisfied”).
Statistical analysis
We used percentages and chi-square tests to describe the distribution of characteristics 
associated with the dichotomous outcome of being informed about breast cancer. We 
imputed missing values for household income using the hot deck method as implemented in 
SUDAAN with marital status and age as explanatory variables.39 To examine the predictive 
power of the independent variables on our outcome, we conducted multivariate logistic 
regression analysis with hierarchical entry in three steps: the block of individual level 
characteristics entered first, then family level characteristics along with individual level 
characteristics, and finally provider characteristics added to the first two levels resulting in a 
full model. Entering the three sets of independent variables sequentially allowed us to 
examine the unique contribution above-and-beyond each group of variables. To enable 
straightforward interpretation of the model’s results, we computed adjusted percentages 
(predicted margins) and 95% confidence intervals derived from the logistic regression 
models. Overall associations were assessed with the Wald F statistic. A p-value of ≤0.05 was 
considered statistically significant. We considered particularly noteworthy those results that 
were both statistically significant and had meaningfully different percentages. All analyses 
were conducted using SAS 9.3, with SUDAAN release 10 (Research Triangle Institute, 
Research Triangle Park, NC).
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The 11,766 respondents in our sample ranged in age from 38 to 80 with an average age of 60 
years. The majority were non-Hispanic white (84%), were married or partnered (79%), had a 
relatively high household income (almost 35% with income of $100,000 or higher), and 
almost half had a college or postcollege education (48%).
Table 1 shows the unadjusted predicted percentages of women responding “yes” and “no” to 
the being informed about breast cancer for the individual, family, and provider-related 
characteristics. Overall, 65% of the women reported being informed about breast cancer and 
35% did not. All variables except education level and personal history of cancer were 
significantly associated with being informed about breast cancer.
Table 2 presents the adjusted percentages from sequential regression models. Model fit 
improved with the addition of family variables and provider variables to the individual 
variables (Hosmer-Lemeshow Wald p-value = 0.18 for individual level variables, 0.95 for 
individual and family level variables, and 0.75 for the model including all levels). Consistent 
with the bivariate results, the model with only individual characteristics showed women who 
perceived their risk of breast cancer as being much lower than most woman their age were 
more likely to report being informed about breast cancer compared with those who 
perceived their risk as being much higher (76% vs. 65%), and women whose mode of survey 
administration was paper were less likely to state they were informed about breast cancer 
(61%) compared with those who took the survey by phone or Internet (74% and 69%). 
Women who had never married were less likely to state they were informed about breast 
cancer as were older versus younger women. A personal history of cancer other than breast 
cancer was not associated with being informed about breast cancer.
With the addition of family level variables into the model, marital status was no longer 
statistically significant and each of the family level variables, except for household income, 
were associated with being informed about breast cancer. Non-Hispanic black women, 
compared with other women, were significantly less likely to report being informed about 
breast cancer. Having a trusted person with whom to speak about breast cancer concerns was 
a predictor of being informed about breast cancer as was having two or more breast cancer-
affected relatives compared with only one affected sister. Social support and family 
communication were significant, although weaker, predictors of being informed about breast 
cancer.
After the final step of adding provider level variables, family communication and social 
support were no longer statistically significant predictors. Race/ethnicity, mode of survey 
administration, and having a trusted person to speak about breast cancer remained 
statistically significant predictors with meaningful percentage differences between 
categories. Among the provider characteristics, being more satisfied versus less satisfied 
with a physician discussion about family cancer history was a strong predictor of being 
informed about breast cancer. Only small percentage differences were seen between the 
categories (no, a little, in depth) of the variable “spoke with a physician about family cancer 
history.” Also statistically significant but less meaningful in terms of percent differences was 
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receipt of genetic counseling (“yes” vs. “no”) and having two or more relatives with breast 
cancer versus one affected sister.
Discussion
We found factors at the individual, family, and provider levels that influenced women being 
informed about breast cancer. In terms of both statistical significance and meaningful 
percentage differences, having a trusted person with whom to speak about breast cancer, a 
lower versus a higher perceived risk of breast cancer, non-Hispanic black race, and higher 
versus lower satisfaction with physician discussion were associated with being informed 
about breast cancer.
Having a trusted person with whom to speak about breast cancer concerns, whether that 
person was a family member, friend, or a physician, remained strongly associated with being 
informed about breast cancer in the final model including all levels. Physicians are the most 
trusted source of health-related information, playing an important role in promoting 
adherence to health behavior and treatment recommendations as well as providing 
appropriate referrals for specialized care.22,23,40 This is reflected in our finding that greater 
satisfaction with physician discussion about cancer in the family significantly contributed to 
being informed about breast cancer. Although over 80% of respondents were satisfied or 
very satisfied with their discussion with their physician, we found as satisfaction increased, 
the percentage of women reporting having enough information about cancer increased. 
Furthermore, speaking in depth versus speaking a little or not speaking with a physician was 
significantly informative for women. Neither social support nor level of familial 
communication remained as significant predictors of being informed about breast cancer in 
the final model that included provider characteristics.
Women who reported having undergone genetic counseling, a process involving a detailed 
discussion about family cancer history, were more likely to report being informed about 
breast cancer although the percentage differences were not large. Previous studies, including 
an analysis of over 3,000 women from a national sample of insured persons for whom 
genetic testing has been reported, demonstrate an association between genetic counseling 
and improved knowledge about BRCA mutations and a greater understanding of genetics.
22,23,40,41
Women with a higher perceived risk of breast cancer were less likely to report being 
informed about breast cancer than women with a lower perceived risk. Communication 
theory suggests attempts to reduce uncertainty may create more uncertainty, especially in 
situations where uncertainty cannot be reduced or avoided.42 This may well describe the 
case for women at high risk for breast cancer or women who believe themselves to be at 
high risk. For these women, uncertainty, already an inherent part of being at high risk, 
becomes an ongoing, chronic process43,44 brought on by having to make healthcare 
decisions about preventive measures such as enhanced screening or prophylactic surgery, or 
by the added worry about breast cancer risk for close family members. These are 
uncertainties not experienced by women believing themselves to be at the same or lower-
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than-average risk of cancer. Thus, uncertainty and the need for more information to answer 
ongoing questions may increase with being or believing oneself to be at high risk.
Our analysis showed that non-Hispanic black women were significantly less likely than non-
Hispanic white, Hispanic, or other women to report being informed about breast cancer. Our 
findings are consistent with studies describing limited knowledge and awareness of cancer 
genetics and BRCA1/2 mutations among African American women as barriers to the uptake 
of genetic counseling and testing.45–47 Underlying this knowledge barrier may be concerns 
about genetic discrimination and a lack of trust in the medical system—a recurrent theme in 
the literature on African Americans.48,49 A lack of provider referrals to genetic services as 
well as high costs and administrative barriers for these services have been shown to limit 
young African American breast cancer survivors’ participation in genetic counseling and 
testing.50,51
All women in this cohort had a sister with breast cancer and almost 25% had more than one 
relative with breast cancer. It is likely that the lived experience with breast cancer among one 
or more relatives provided practical knowledge about breast cancer. This is suggested by our 
finding that having more affected relatives than a single sister predicted being informed 
about breast cancer.
Among the strengths of this study are the high response rate from a targeted subset of 
women in the larger Sister Study, and the large sample size that allowed us to investigate a 
number of characteristics in some detail. One limitation of this study is that our data are self-
reported and therefore subject to recall bias and social desirability bias (a tendency by 
respondents to answer questions in a way they believe will be viewed favorably). However, 
for many of the factors we studied, self-report was the only practical method of soliciting 
information. Additionally, the cross-sectional nature of our study does not allow for 
determining the direction or the causal nature of relationships between variables of interest. 
Because we were primarily interested in the potential sources of information for women 
with a family history of cancer, our outcome of interest was worded in terms of “having all 
the information I need” for a discussion about cancer. We recognize there are important 
factors beyond information alone that would influence the subjective assessment of “having 
enough knowledge to speak about breast cancer.” These might include self-efficacy to 
engage in discussions, comfort in having conversations about cancer family history, or 
family dynamics, which we did not measure in the survey. Despite these limitations, our 
results highlight important factors that can influence a woman’s confidence in her 
knowledge about cancer risk and identify opportunities for increasing that knowledge.
Conclusions
Our key findings point to having a trusted person with whom to discuss cancer concerns, and 
satisfying physician encounters as significant contributors to being informed about breast 
cancer. The measure of successful communication about cancer risk in families has often 
focused on uptake of genetic counseling and testing by at-risk relatives, or on the depth of 
knowledge being conveyed by medical professionals, our findings also suggest that simply 
conveying objective risk information may not reduce uncertainty or increase confidence in 
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cancer knowledge.52,53 Rather, successful communication may depend on the depth and 
tenor of discussions with healthcare providers and within other trusted relationships—a 
situation more likely to be achieved through long-term relationships that foster trust and 
through conversations that go beyond evidence and risk.54
Advances in genetics and molecular medicine along with mass media attention have 
increased public awareness of the importance of cancer family history. Uptake of genetic 
testing through traditional genetic counseling channels or through direct to consumer testing, 
combined with the decreasing cost of testing, makes discussions about genetics within the 
family setting more likely to occur, thus making ease of obtaining information more urgent. 
However, an increase in information may not necessarily translate to less uncertainty or a 
more complete understanding of what is currently known about cancer family history or 
genetic heritability. Effectively incorporating genetic knowledge into medicine and into 
discussions within families requires a better understand how the public makes sense of this 
information. This insight would guide the development of tools or strategies that make 
family history and genetics relevant and practically useful for individuals needing to make 
decisions that could impact their own or a family member’s health.
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Table 1
Demographic and Psychosocial Characteristics of Being Informed About Breast Cancer
Characteristics
Being informed, N = 7,644 n (row
%)
Not being informed, N = 4,084 n 
(row%) pa
Individual level
 Respondent’s age at special survey 0.005
  38–49 983 (62.2) 597 (37.8)
  50–59 2,610 (64.7) 1,433 (35.3)
  60–69 2,753 (65.7) 1,435 (34.3)
  70–80 1,298 (67.7) 619 (32.3)
 Education 0.12
  ≤ high school/GED 1,219 (63.1) 712 (36.9)
  Some college 2,703 (65.5) 1,424 (34.5)
  College graduate 2,007 (64.9) 1,084 (35.1)
  Postgraduate 1,714 (66.5) 864 (33.5)
 Marital status <0.01
  Never married 75 (58.1) 54 (41.8)
  Partnered 6,099 (65.9) 3,153 (34.1)
  Widowed/divorced/separated 1,468 (62.6) 877 (37.4)
 Personal history of cancer 0.07
  Yes 839 (67.5) 404 (32.5)
  No 6,805 (64.9) 3,680 (35.1)
 Perceived chance of developing breast cancer <0.001
  Much lower than most women your age 223 (76.1) 70 (23.9)
  Lower 519 (65.3) 276 (34.7)
  About the same 2,561 (66.2) 1,305 (33.8)
  Higher 3,535 (64.0) 1,985 (36.0)
  Much higher 783 (64.4) 432 (35.6)
 Mode of survey administration
  Telephone 947 (73.1) 349 (26.9) <0.0001
  Internet 3,135 (68.3) 1,457 (31.7)
  Paper 3,562 (61.0) 2,278 (39.0)
Family level
 Household income
  <$20,000 290 (62.8) 172 (37.3) <0.0001
  $20,000–$49,999 1,449 (62.1) 884 (37.9)
  $50,000–$99,999 3,144 (65.2) 1,681 (34.8)
  $100,000–$200,000 2,149 (66.4) 1,089 (33.6)
  More than $200,000 611 (70.3) 258 (29.7)
 Family communication <0.0001
  Low level 2,528 (62.4) 1,526 (37.6)
  Medium level 2,404 (65.4) 1,270 (34.6)
  High level 2,703 (67.7) 1,287 (32.3)
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Characteristics
Being informed, N = 7,644 n (row
%)
Not being informed, N = 4,084 n 
(row%) pa
 Race/ethnicity <0.0001
  Non-Hispanic white 6,514 (66.2) 3,323 (38.8)
  Non-Hispanic black 608 (55.5) 487 (44.5)
  Hispanic 327 (66.1) 168 (34.0)
  Other 193 (64.6) 106 (35.5)
 Have trusted person with whom to discuss cancer <0.0001
  Agree/strongly agree 7,020 (68.6) 3,221 (31.5)
  Strongly disagree/disagree 565 (40.5) 830 (59.5)
 How recent was sister’s diagnosis 0.03
  3–5 years 1,896 (63.8) 1,074 (36.2)
  5–10 years 3,065 (64.7) 1,669 (35.3)
  10+ years 2,672 (66.8) 1,331 (33.3)
 Breast cancer family history <0.0001
  1 affected relatives 5,675 (63.9) 3,210 (36.1)
  2 affected relatives 1,724 (68.9) 780 (31.2)
  3–5 affected relatives 245 (72.3) 94 (27.7)
 Social support
  1st quartile (lowest social support score) 1,499 (59.0) 1,040 (41.0) <0.0001
  2nd 1,634 (65.5) 862 (34.5)
  3rd 2,270 (66.4) 1,147 (33.6)
  4th quartile (highest social support score) 1,950 (68.4) 900 (31.6)
Provider level
 Spoke with doctor about cancer family history <0.0001
  Yes, a little/a lot 6,748 (66.4) 3,423 (33.6)
  No 877 (57.6) 646 (42.4)
 Received genetic counseling <0.0001
  Yes 810 (74.9) 272 (25.1)
  No 6,823 (64.2) 3.806 (35.8)
 Satisfaction with provider’s discussion <0.0001
  Very satisfied 3,260 (76.0) 1,029 (24.0)
  Satisfied 3,353 (64.2) 1,868 (35.8)
  Neither satisfied nor dissatisfied 827 (49.0) 861 (51.0)
  Dissatisfied 139 (33.9) 271 (66.1)
  Very dissatisfied 37 (52.9) 33 (47.1)
a
p-Values from chi-square tests.
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